Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigms ACL Phase 2 Clinical Trial Success

Nov 14, 2017 at 3:06 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment